Publication | Open Access
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
53
Citations
34
References
2013
Year
Dovitinib showed modest antitumour activity with manageable toxicities in heavily pretreated patients with advanced GISTs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1